Birznieks Gunther
SEC insider (Form 3/4/5 filer). CIK 0001702031. SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in WASHINGTON, DC.
Companies Birznieks Gunther has filed insider reports for
- Vanda Pharmaceuticals Inc. (VNDA): Officer, SVP, Business Development
Birznieks Gunther
CIK: 0001702031
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VNDA
Vanda Pharmaceuticals Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 2, 2026VNDA
Vanda Pharmaceuticals Inc.
SaleDirect42.4K shares at avg. $8.27$351K - Feb 18, 2026VNDA
Vanda Pharmaceuticals Inc.
AwardDirect125K shares- - Mar 1, 2025VNDA
Vanda Pharmaceuticals Inc.
Tax PaymentDirect26.9K shares at avg. $4.76$128K - Feb 18, 2025VNDA
Vanda Pharmaceuticals Inc.
AwardDirect125K shares-
1-4 of 4 transactions